Open house Arzneimittelrabattverträge zum Wirkstoff Axitinib, ATC L01EK01

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse offers all interested pharmaceutical companies discount agreements with the above-mentioned active substance without making a selection decision. The contract award decisions are made within the framework of an “Open House model”. The contracts offered are not exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse. In the Open House model, uniform conditions apply to all participants. Contract content, terms and conditions, and access procedures are uniform—individual negotiations are not conducted. Contract terms are a maximum of 24 months; the earliest contract commencement date is 01.07.2025. All contracts end no later than 24 months after the date of the earliest contract commencement, irrespective of the date of the respective contract award decision. Accession and/or conclusion of a contract may take place within the 24-month period, each time on the first day of every month. There is a right of termination of 6 weeks for the end of the month in each case, in accordance with the provisions of the contract. Further information on the…

TENDER BRIEF

TENDER DOCUMENTS